Alzheimer’s Disease (AD) Services
There is an urgent need to identify individuals manifesting initial symptoms of AD for the purpose of testing of new agents in clinical trials, to facilitate lifestyle modifications that impact disease course.
-
Most popular related searches
Details
In the event that disease modifying therapies become mainstream, early identification of cognitive impairments combined with treatment will become crucial to maintain quality of life and improve outcomes.
Although several diagnostic tests are available that can identify patients in the earliest stages of the disease, these tests are prohibitively expensive (amyloid PET) or invasive (spinal tap) and are not feasible for screening millions of at-risk individuals.
New screening tools that are inexpensive, scalable, and minimally invasive are urgently needed to combat the looming Alzheimer’s disease epidemic.
Customer reviews
No reviews were found for Alzheimer’s Disease (AD) Services. Be the first to review!